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Background: The presence of viable myocardium may predict response to cardiac resynchronization
therapy (CRT). The aim of this study is to evaluate in patients with left ventricular (LV) dyssynchrony
whether response to CRT is related to myocardial viability in the region of the pacing lead. Methods:
Forty-nine consecutive patients with advanced heart failure, LV ejection fraction< 35%, QRS duration>
120ms and intraventricular asynchronism≥ 50ms were included. Dobutamine stress echocardiography
was performed within the week before CRT implantation. Resting echocardiography was performed 6
months after CRT implantation. Viability in the region of LV pacing lead was defined as the presence of
viability in two contiguous segments. Response to CRT was defined by evidence of reverse LV remodeling
(≥15% reduction in LV end-systolic volume). Results: Thirty-one patients (63%) were identified as
responders at follow-up. The average of viable segments was 5.9 ± 2 in responders and 3.2 ± 3 in
nonresponders (P = 0.0003). Viability in the region of the pacing lead had a sensitivity of 94%, a
specificity of 67%, a positive predictive value of 83%, and a negative predictive value of 86% for the
prediction of response to CRT. Conclusions: In patients with LV dyssynchrony, reverse remodeling after
CRT requires viability in the region of the pacing lead. This simple method using echocardiography
dobutamine for the evaluation of local viability (i.e., viability in two contiguous segments) may be
useful to the clinician in choosing the best LV lead positioning. (Echocardiography 2010;27:668-676)
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Intraventricular conduction delay is frequent
in patients with dilated cardiomyopathy and can
result in inefficient contraction and reduced ven-
tricular performance. Cardiac resynchronization
therapy (CRT) is a valuable therapeutic option
for such patients and has been shown to im-
prove heart failure symptoms, mitral regurgita-
tion (MR), and to reduce hospitalization and
mortality in well-selected patients.1–7 Between
30% and 40% of patients with congestive heart
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failure and QRS duration > 120 ms, however,
do not clinically improve after CRT.6,8 Factors
that influence whether patients will respond to
a therapy are not completely understood. To
date, the main approach identifying CRT can-
didates has been QRS prolongation and me-
chanical dyssynchrony.9 Contractile reserve may
represent a key element in the resynchroniza-
tion process. Because electrical conduction and
regional wall thickening are influenced by the
extent of myocardial fibrosis, it has been hypoth-
esized that long-term response to CRT could cor-
relate with myocardial viability in patients with
left ventricular (LV) dysfunction. Using nuclear
myocardial perfusion imaging (2C1Ti),10,11 mag-
netic resonance imaging (MRI)12–14 or dobu-
tamine stress echocardiography (DSE),15–19 stud-
ies have demonstrated the importance of LV
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viability in predicting response to CRT. Further-
more, scar tissue in the LV pacing lead region may
prohibit response to CRT.20 This study sought to
prospectively validate the potential impact of my-
ocardial reserve (i.e., global and in the LV pacing
lead) as assessed during DSE on LV reverse remod-
eling after CRT in patients with echocardiographic
evidence of LV dyssynchrony at baseline.
Materials and Methods:
From May 2005 to March 2008, 50 patients
(mean age 66 ± 12 years, 34 (69%) male)
were prospectively enrolled. The inclusion criteria
were as follow: (1) New York Heart Association
(NYHA) functional class III and IV heart failure,
(2) QRS duration ≥ 120 ms, (3) chronic LV sys-
tolic dysfunction (LV ejection fraction ≤ 35%),
(4) basal LV dyssynchrony ≥ 50 ms, (5) opti-
mal medical treatment for heart failure includ-
ing angiotensin-converting enzyme inhibitors or
AT1 receptor antagonists diuretics, beta-receptor
blockers, and spironolactone when tolerated, and
(6) sinus rhythm. Patients with recent myocar-
dial infarction, coronary revascularization (<6
months), and presenting standard contraindica-
tions to DSE were excluded. One patient was
subsequently excluded for the failure of CRT
implantation. All patients underwent coronary
angiograms before implantation to exclude treat-
able ischemic heart disease. Etiology was consid-
ered ischemic in the presence of significant coro-
nary artery disease (≥50% stenosis in one or more
of the major epicardial coronary arteries) and/or a
history of myocardial infarction or prior revascu-
larization. All patients provided informed consent.
The study protocol conforms to the ethical guide-
lines of the 1975 Declaration of Helsinki and was
approved by local ethics committee.
Study Design:
Patients underwent clinical examination, 12-lead
electrocardiography (EKG), resting echocardiog-
raphy, and DSE, within the week before biventric-
ular pacing implantation. Follow-up clinical and
echocardiographic examinations were obtained
at 6 months. Responders were defined by ≥ 15%
decrease in LV end-systolic volume.
Echocardiographic Assessment:
Echocardiographic measurements were per-
formed by two observers blinded to patient’s sta-
tus using Philips Sonos 5500 or 7500 instrument
with a 2.5-MHz transducer (Philips Medical Sys-
tems, Amsterdam, The Netherlands). LV volumes
and ejection fraction were measured using the
modified biplane Simpson’s rule. LV stroke vol-
ume was calculated by multiplying the LV out-
flow tract area by the LV outflow tract velocity–
time integral measured by pulsed wave Doppler.
The proximal isovelocity surface area (PISA) was
used to assess MR severity and to measure effec-
tive regurgitant orifice (ERO) area and regurgitant
volume.21 Aortic and pulmonary Doppler flows
were recorded in the pulsed mode from the api-
cal four-chamber view and parasternal short-axis
view, respectively. Aortic and pulmonary ejection
delays were defined as the delay between the on-
set of the QRS complex on the surface EKG and
the onset of the aortic and pulmonary waves. The
interventricular delay was defined as the time dif-
ference between the aortic and pulmonary elec-
tromechanical delay.22
Intraventricular Asynchronism Measurement:
Tissue Doppler imaging (TDI) was performed in
the pulsed-wave Doppler mode from apical views
to assess longitudinal myocardial regional func-
tion, analyzing the septal, inferior, lateral, ante-
rior, and posterior walls.22 Velocity profiles were
recorded with a sample volume placed in the
middle of the basal segment of each wall. Gain
and filters were adjusted as needed to eliminate
background noise and to allow for a clear tissue
signal. TDI signals were recorded at a sweep of
100 mm/s. The electromechanical delay defined
as the delay between the onset of the QRS com-
plex on the surface EKG and the onset of the sys-
tolic TDI wave were measured by an independent
observer (MS or PG). Intraventricular asynchro-
nism was defined as the time difference between
the shortest and longest electromechanical delay
among the five LV walls.22
Assessment of Contractile Reserve:
All patients underwent DSE according to a low-
dose infusion protocol. Patients received 5, 10,
15, and 20 µg/kg per minute of dobutamine in
3-minute stage, with echocardiographic images
recorded at each stage.23,24 Heart rate and blood
pressure were monitored during each stage. Cri-
teria for stopping the dobutamine infusion in-
cluded (1) hypotension (systolic blood pressure<
90mmHg), (2) angina, (3) significant arrhythmias
(atrial fibrillation, bigeminy, ventricular tachycar-
dia), (4) attainment of 85% maximal predicted
heart rate. The regional wall motion was assessed
by the 16-segment model recommended by the
American Society of Echocardiography.25 Thus, a
normal or hyperkinetic segment was graded as
1, hypokinetic as 2, akinetic as 3, dyskinetic as 4.
The stress images at the dobutamine dose show-
ing the maximum augmentation of wall motion
were compared with baseline images. A segment
was considered to have contractile reserve if after
dobutamine the wall motion improved by one
grade. Viability in the region of the LV pacing




CRT Implantation and LV Lead Position:
A coronary sinus venogram was obtained using
balloon catheter, followed by the insertion of the
LV pacing lead (Guidant Corporation, St Paul,
MN, USA or Medtronic Inc, Minneapolis, MN,
USA) in the coronary sinus. The preferred po-
sition was a lateral or posterolateral vein. The
right atrial and ventricular leads were positioned
conventionally. All leads were connected to a
dual-chamber biventricular pacing (Guidant Cor-
poration, or Medtronic Inc). One day after im-
plantation, the LV lead position was assessed
from a chest x-ray, using frontal and lateral views
(scored anterior, lateral, or posterior).26
Statistical Analysis:
Results are expressed as mean ± SD. Inter- and
intraobserver variability for measurement of the
asynchrony as for quantification of wall motion
score index (WMSI) was determined from the
analysis of Doppler echocardiographic images
of 15 randomly selected patients by two inde-
pendent observers (MS and PG). Results were
compared with a one-way analysis of variance,
Pearson correlation coefficient, and Bland-Altman
method. Baseline data of responders versus non-
responders group were compared for statistical
significance using t-test or chi-square test, as
appropriate. Baseline and post-CRT MR severity
were compared within groups using paired t-test
or chi-square test, as appropriate. Linear regres-
sion analyses were used to evaluate the relation-
ship between CRT response, assessed as the per-
centage of change in LV volume, and the percent-
age of change in echocardiographic data.
Results:
Patients:
Table I summarizes baseline characteristics of the
population before CRT. Device implantation was
successful in all patients and one patient devel-
oped pneumothorax after CRT implantation. LV
pacing threshold were not different between re-
sponders and nonresponders (1.18 ± 0.70 vs.
1.75 ± 0.5, P = 0.17). In the subgroup of pa-
tients with CAD, no patients experience angina,
electric, or regional wall motion modification at
peak stress (20 µg/kg per minute) suggestive of
ischemia.
Reproducibility of Asynchronism and WMSI:
There were excellent correlations (r ≥ 0.96) be-
tween intra- and interobserver analysis of via-
bility in the region of the pacing lead and for
WMSI. Intra- and interobserver relative differ-
ences were < 3% for all parameters. The Bland-
Altman method showed an excellent agreement
between inter- and intraobserver measurement
in both low and high values of asynchronism or
WMSI.
TABLE I
Demographic and Clinical Data
All Patients Responders Nonresponders
Variables (n = 49) (n = 31, 63%) (n = 18, 37%) P-Value
Demographic data
Age (years) 66 ± 12 67 ± 10 65 ± 14 0.55
Male, n (%) 34 (69) 21 (68) 16 (72) 0.74
CAD, n (%) 34 (69) 20 (65) 14 (78) 0.32
Clinical data
QRS duration (ms) 164 ± 30 166 ± 31 153 ± 26 0.14
LBBB, n (%) 30 (61) 20 (65) 10 (56) 0.53
RBBB, n (5) 3 (6) 2 (6) 1 (6) 0.90
IVCD, n (%) 8 (16) 3 (10) 5 (28) 0.10
PR, ms 185 ± 42 175 ± 32 202 ± 51 0.05
Pre-CRT pacing, n (%) 8 (16) 6 (19) 2 (11) 0.45
NYHA III/IV, n (%) 33 (67)/16 (33) 23 (74)/8 (26) 10 (56)/8 (44) 0.18
Medication
Diuretic, n (%) 49 (94) 29 (94) 17 (94) 0.90
Beta-blockers, n (%) 46 (94) 28 (90) 18 (100) 0.09
ACEi, n (%) 34 (69) 21 (68) 13 (72) 0.74
AR Blockers, n (%) 14 (29) 10 (33) 4 (22) 0.41
Digoxin, n (%) 14 (29) 5 (16) 9 (50) 0.01
Spironolactone, n (%) 31 (63) 17 (55) 14 (78) 0.10
CAD = coronary arteries disease; LBBB = left bundle branch block; RBBB = right bundle branch block; IVCD = intraventricular
conduction defect; ACEi = angiotensin converting enzyme inhibitors; and AR = angiotensin receptors.
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TABLE II
Echocardiographic Data
All Patients Responders Nonresponders
Variables (n = 49) (n = 31, 63%) (n = 18, 37%) P-Value
LV geometry and function
LV End-Diastolic Volume (ml)
Pre-CRT 216 ± 65 207 ± 65 231 ± 65 0.22
Late post-CRT 205 ± 74 180 ± 64∗ 248 ± 73∗ 0.0013
LV End-Systolic Volume (ml)
Pre-CRT 180 ± 62 173 ± 63 191 ± 60 0.32
Late post-CRT 158 ± 68 131 ± 56∗ 203 ± 65∗ 0.0002
LV Stroke Volume (ml)
Pre-CRT 43 ± 12 39.5 ± 11 48 ± 14 0.02
Late post-CRT 50 ± 12 52 ± 9∗ 48 ± 15 0.31
LV Ejection Fraction (%)
Pre-CRT 19 ± 7 18.5 ± 7 20 ± 7 0.59
Late post-CRT 24 ± 9 27.5 ± 9∗ 19 ± 6 0.0009
Mitral regurgitation
ERO (mm2)
Pre-CRT 18 ± 13 18 ± 12 20 ± 15 0.67
Late post-CRT 11 ± 12 6 ± 6∗ 21 ± 14 <0.0001
Regurgitant Volume (ml)
Pre-CRT 30 ± 26 30 ± 28 29.5 ± 22 0.9
Late post-CRT 20 ± 19 12 ± 13∗ 33 ± 22 <0.0001
Severe MR, n (%)
Pre-CRT 23 (47) 14 (45) 9 (50) 0.74
Late post-CRT 12 (24.5) 2 (6.5)∗ 10 (55.5) <0.0001
LV = left ventricular; CRT = cardiac resynchronization therapy; ERO = effective regurgitant orifice area; and MR =
mitral regurgitation; severe MR: ≥ 20 mm2, ∗Significant difference (P < 0.05) between pre-CRT and late post-CRT data.
CRT Response and Echocardiographic
Parameters:
Thirty-one patients (63%) were classified as re-
sponders to CRT, according to the predefined cri-
terion of reduction in LV end-systolic volume. The
response rate of patients with ischemic and non-
ischemic cardiomyopathy was not statistically sig-
nificant (59% vs. 73%, P = 0.52). Before CRT, LV
stroke volume was significantly higher in nonre-
sponders (Table II) and there was no other sig-
nificant difference between the two groups with
regard to baseline echocardiographic data. In re-
sponders, LV ejection fraction improved signifi-
cantly from 19 ± 7% to 28 ± 9% (P < 0.05), and
a significant reduction in LV end-diastolic (207 ±
65 ml to 180 ± 64 ml) and LV end-systolic vol-
ume (173 ± 63 ml to 131 ± 56 ml) was ob-
served (Table II). Prevalence of MR between re-
sponders and nonresponders was not statistically
different before CRT (89% vs. 87%, P = 0.85).
Moreover, there was no significant difference be-
tween groups regarding the prevalence of severe
MR (ERO ≥ 20 mm2) and MR severity. In respon-
ders, ERO and regurgitant volume were signifi-
cantly reduced following CRT (66 ± 25%, from
18 ± 12 mm2 to 6 ± 6 mm2, P < 0.001; 62 ±
29%, from 30 ± 28 ml to 12 ± 13 ml, P <
0.0001).
Contractile Reserve and LV Remodeling:
All patients completed DSE protocol without
complications. During low-dose dobutamine in-
fusion, responders had less akinetic segments (8±
3 vs. 10 ± 3, P = 0.02) and significantly higher
number of viable segments (5.9 ± 2 vs. 3.2 ± 3,
P = 0.0003) than nonresponders (Table III). Re-
duction in LV end-systolic volume after CRT was
mainly related to the improvement in WMSI dur-
ing dobutamine infusion (r = 0.49, P = 0.0003)
(Fig. 1).
Viability in the Region of the Pacing Lead and
Response to CRT:
The presence of viability in the region of the pac-
ing lead was more frequent in responders than
in nonresponders (94% vs. 33%, P < 0.0001). In
nonresponders, 12 patients had LV lead placed in
myocardial region without viability. In contrast,
LV lead positioned in a region with viability was
observed in 29 of the 31 responders (Fig. 2) and
was associated with greater end-systolic volume
reduction (8.6 ± 3.0 vs. 21 ± 3, P < 0.0001)
(Fig. 3). Viability in the region of the pacing lead
had a sensitivity of 94%, a specificity of 67%, a
positive predictive value of 83% and a negative





Baseline LV Asynchronism, Function, and Viability Data
All Patients Responders Nonresponders
Variables (n = 49) (n = 31, 63%) (n = 18, 37%) P-Value
Asynchronism
Interventricular (ms) 45 ± 28 45 ± 30 46 ± 24 0.92
Intraventricular (ms) 82 ± 25 84 ± 25 82.5 ± 26 0.87
No. of akinetic segments
Rest 10 ± 3 9 ± 3.5 10.5 ± 3 0.16
Stress 8.5 ± 3 8 ± 3∗ 10 ± 3∗ 0.02
Wall motion score index
Rest 3.5 ± 0.4 3.5 ± 0.4 3.6 ± 0.2 0.16
Stress 3.1 ± 0.5 3 ± 0.4∗ 3.3 ± 0.4∗ 0.0069
Viability
No. of viable segments 4.9 ± 2.7 5.9 ± 2 3.2 ± 3 0.0003
≥ 4 viable segments, n (%) 31 (75) 30 (97) 7 (39) <0.0001
Viability in the region of the lead, n (%) 35 (71) 29 (94) 6 (33) <0.0001
Lead placement
Posterior, n (%) 32 (65) 21 (68) 11 (61) 0.87
Lateral, n (%) 15 (31) 10 (32) 5 (28) 0.33
Anterior, n (%) 2 (4) 0 (0) 2 (11) . . .
∗Significant difference (P < 0.05) between pre-CRT and late post-CRT data.
Viability in the region of the pacing lead was
a better predictor of response in the group of pa-
tients with nonischemic cardiomyopathy versus
patients with ischemic cardiomyopathy (sensibil-
ity 100% vs. 90%, specificity 75% vs. 64%, posi-
tive predictive value 100% vs. 78%, and negative
predictive value 100% vs. 82%).
Discussion:
The main finding of the present study showed
that for long-term response in ischemic and non-
ischemic cardiomyopathy, CRT requires the pres-
ence of myocardial viability. A direct relation
between improvement in WMSI, assessed us-
ing low-dose dobutamine infusion, and the
Figure 1. Correlation between
changes in WMSI (rest/dobutamine)
and changes in LV end systolic volume
after CRT.
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Figure 2. Percentage of responders to
CRT based on the presence or absence
of viability in the region of the pacing
lead (local+/local −).
improvement in LV volume after CRT was ob-
served. More importantly, our results suggest that
for LV remodeling in patients with significant LV
dyssynchrony, CRT requires the presence of my-
ocardial viability in the LV lead target site. This
underlines the importance of assessing viability
before device implantation in order to guide LV
lead positioning to ensure a pacing benefit.
Comparisons with Previous Studies:
Various studies have demonstrated that patients
with QRS duration ≥ 120 ms and extensive base-
line LV dyssynchrony have a high likelihood of
response to CRT, whereas patients without base-
line LV dyssynchrony do not respond to CRT.
More recently, studies have evaluated the re-
lation between myocardial viability and CRT.
However, the results are scarce and patients in-
cluded in those studies did not necessarily have
significant intraventricular asynchronism. Using
contrast-enhanced MRI, Bleeker et al.20 demon-
strated in 40 patients with ischemic cardiomy-
opathy that CRT did not reduce LV dyssynchrony
when transmural scar tissue in the posterolateral
LV segments is present. Only 14% of patients with
posterolateral scar showed response to CRT. Even
in the subset of patients with intra-ventricular
asynchrony and posterolateral scar, the response
rate was low (n = 2, 18%). Ypenburg et al. re-
cently observed in 31 CRT patients that respon-
ders showed an increase in strain in the region of
the pacing lead during low-dose dobutamine in-
fusion while nonresponders had no contractile re-
serve.17 Furthermore, Lim et al.,16 demonstrated
Figure 3. Changes in LV end systolic
volume after CRT based on the pres-
ence of viability in the region of the
pacing lead (local+/local −).
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Figure 4. Changes in LV end systolic
volume after CRT based on the num-
ber of viable segments (<5 vs. ≥5) in
responders with viability on the region
of the pacing lead.
that only patients (n= 19) with contractile reserve
in the LV target site for pacing (lateral, postero-
lateral) presented a decrease in LV dyssynchrony
with CRT. The authors also showed that the mean
increase of LV stroke volume was greater in pa-
tients with contractile reserve (22% vs. 0%). In
line with these results, the present study demon-
strated that responders to CRT showed viability in
the region of the pacing lead significantly more
often than nonresponders. Of interest, 29 of 31
responders (94%) had viability in the region of
the pacing lead. In the nonresponders group, 7
patients (39%) had ≥ 5 total viable segments
(6.1± 1.5) in the absence of viability in the region
of the pacing lead. Moreover, in the responders
group, 16 patients (58%) had ≤ 5 total viable
segments (4.3 ± 0.8) in the presence of viability
in the region of the pacing lead. Therefore, it ap-
pears likely that viability of the paced segments
is the crucial factor mediating the influence of vi-
ability (local viability vs. global) on response to
CRT. However, in accordance with other studies
concerning the relation between the burden of
global viability and LV remodeling after CRT, re-
sponders with viability in the region of the pacing
lead and with ≥ 5 total viable segments demon-
strated a more important LV end-systolic reduc-
tion after CRT (30 ± 4% vs. 21 ± 2%, P = 0.01)
than those with< 5 total viable segments (Fig. 4).
In line with our results, Ypenburg et al.15 evalu-
ated and demonstrated that beside the presence
of LV dyssynchrony, myocardial contractile re-
serve (resulting in ≥ 7.5% increase in LV ejection
fraction during dobutamine infusion) predicts LV
reverse remodeling and improvement in LV func-
tion, 6 months after CRT implantation. Another
study19 with 67 patients including 34% ischemic
cardiomyopathy revealed that the presence of
contractile myocardial reserve was an indepen-
dent predictor of event-free survival after CRT.
Using a cutoff value of 25% increase in dobu-
tamine LV ejection fraction exhibits a sensitivity
of 70% and a specificity of 62% for predicting
major cardiac events. Hummel et al.,18 in 21 CRT
patients (100% ischemic), evaluated myocardial
viability by myocardial contrast echocardiogra-
phy. The LV systolic performance was assessed by
echocardiography on the day after implantation.
In that study, acute improvement in LV stroke vol-
ume was significantly correlated with the degree
of viability as determined by the perfusion score
index.
Mechanisms of LV Remodeling Following CRT:
There are several potential mechanisms by which
myocardial viability may influence LV remodeling
following CRT. An intuitive explanation is that
resynchronization reverses wasted work toward
cardiac output only in viable segments where
some potential for wall thickening exists. Akinetic
regions that are largely nonviable contribute lit-
tle to systolic performance, whether or not their
relatively passive motion dyssynchronized. Also,
slower conduction velocities through fibrotic re-
gion could preclude electrical resynchronization.
In agreement with this hypothesis, in the study by
Bleeker et al.,20 patients with posterolateral scar
did not show improvement on echocardiographic
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parameters and LV dyssynchrony remained un-
changed after CRT implantation. Our present re-
sults confirm earlier suggestions that the absence
of viability in the region of the pacing lead may
prohibit response to CRT; also the positive predic-
tive value of echocardiographic response is high
in presence of viability in the region of the pacing
lead; moreover, in those patients, the magnitude
of LV remodeling is clearly influenced by the bur-
den of global viability. Of interest, in our study,
the criterion used to define the presence of “sig-
nificant” viability in the region of the LV pacing
lead (presence of viability in 2 contiguous seg-
ments) is simple, rapid, and easily applicable in
the context of clinical evaluation before CRT. This
underlines the importance of assessing local via-
bility in order to guide LV positioning. Region of
myocardium without viability should be avoided
as a final resting place for LV lead placement to
maximize the possibility of therapeutic benefit.
Study Limitations:
Some limitations should be acknowledged. Our
study contains only patients with current criteria
for CRT implantation and significant LV dyssyn-
chrony. The population studied was not com-
pletely homogenous since it was composed of
patients withmyocardial dysfunction of ischaemic
and nonischemic origin. However, this represents
our daily patients referred for CRT. Moreover,
biventricular pacing is still a challenging therapy
in both settings. Although, the accuracy of x-ray
for assessing the lead position is imperfect, there
was a good correlation between viability in the
region of the pacing lead and response to CRT.
Conclusion:
In patients with heart failure and LV dyssyn-
chrony, reverse remodeling after CRT requires vi-
ability in the region of the pacing lead. Identi-
fication of myocardial viability should therefore
be routinely performed before CRT to guide LV
pacing lead implantation and improve patient’s
prognosis.
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